Citations of this article
Mendeley users who have this article in their library.


A substantial body of evidence has accumulated linking an increased incidence of cardiovascular disease in patients with acute kidney injury (AKI), chronic kidney disease (CKD), and end-stage renal disease (ESRD). A multitude of novel risk factors related to decreased kidney function might interact with the renal and systemic immune systems involved in renal injury and repair to participate in accelerated atherogenesis (Immune inflammation-Renal injury-Atherosclerosisthe IRA Paradigm). In this review, we will discuss several of these novel risk factors and present the potential for the role of the immune-inflammatory system in accelerated atherosclerosis of kidney disease. 2011 International Society of Nephrology.




S., S., & S.V., S. (2011). Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney International. S. Swaminathan, Division of Nephrology, University of Arkansas for Medical Sciences, Central Arkansas Veteran Affairs Health System, 4301 West Markham Street, Little Rock, AR 72205, United States. E-mail: sswaminathan@uams.edu: Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom). Retrieved from http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=2012374004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free